These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10924700)

  • 41. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
    Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
    Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rat mesencephalic neuronal cells cultured for different periods as a model of dopamine transporter ontogenesis.
    Valchár M; Hanbauer I
    Mol Neurobiol; 1995; 11(1-3):111-9. PubMed ID: 8561956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.
    Zhen J; Maiti S; Chen N; Dutta AK; Reith ME
    Eur J Pharmacol; 2004 Dec; 506(1):17-26. PubMed ID: 15588620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue.
    Wu X; Gu HH
    Gene; 1999 Jun; 233(1-2):163-70. PubMed ID: 10375632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cloning of the cocaine-sensitive bovine dopamine transporter.
    Usdin TB; Mezey E; Chen C; Brownstein MJ; Hoffman BJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11168-71. PubMed ID: 1722321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.
    Pifl C; Zezula J; Spittler A; Kattinger A; Reither H; Caron MG; Hornykiewicz O
    FASEB J; 2001 Jul; 15(9):1607-9. PubMed ID: 11427501
    [No Abstract]   [Full Text] [Related]  

  • 53. Generation of transporter-specific antibodies.
    Miller GW; Gilmor ML; Levey AI
    Methods Enzymol; 1998; 296():407-22. PubMed ID: 9779463
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular effects of dopamine--beyond oxidative mechanisms.
    Pifl C; Kattinger A; Reither H; Hornykiewicz O
    Parkinsonism Relat Disord; 2002 Sep; 8(6):433-7. PubMed ID: 12217632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporter.
    Seitz G; Bruchelt G; Kuci Z; Roginsky VA; Wolburg H; Stegmann HB; Niethammer D
    Med Pediatr Oncol; 2000 Dec; 35(6):612-5. PubMed ID: 11107129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-neuronal antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis.
    Kürtüncü M; Tüzün E; Kaya D; Içöz S; Bariş Baslo M; Ertaş M; Akman-Demir G; Eraksoy M
    J Headache Pain; 2008 Oct; 9(5):333-5. PubMed ID: 18696177
    [No Abstract]   [Full Text] [Related]  

  • 57. A human recombinant monoclonal antibody to cocaine: Preparation, characterization and behavioral studies.
    Eubanks LM; Ellis BA; Cai X; Schlosburg JE; Janda KD
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4664-4666. PubMed ID: 25205191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells.
    Rotman A; Daly JW; Creveling CR; Breakefield XO
    Biochem Pharmacol; 1976 Feb; 25(4):383-8. PubMed ID: 945744
    [No Abstract]   [Full Text] [Related]  

  • 59. A potential vaccine for cocaine abuse prophylaxis?
    Gallacher G
    Immunopharmacology; 1994; 27(1):79-84. PubMed ID: 8206756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy for cocaine addiction.
    Landry DW
    Sci Am; 1997 Feb; 276(2):42-5. PubMed ID: 9000762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.